Clinical Trial Update: Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating nab-paclitaxel plus cisplatin and gemcitabine in combination with Tumor Treating Fields for metastatic pancreatic cancer; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• Tumor Treating Fields (TTF) (tumor treating fields)

Snippet

Sponsor: Mayo Clinic | Conditions: Pancreas Cancer, Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING